drugset / Trial / NCT02026011

Naltrexone for Individuals of East Asian Descent

NCT02026011

RandomizedCrossoverTriple-blindTreatment

Summary

This study will elucidate the pharmacogenetic effects of the Asn40Asp SNP of the OPRM1 gene on biobehavioral and neural markers of response to naltrexone in individuals of East Asian descent, an ethnic group most likely to express the positive predictive allele.

Timeline

Start
2013-12
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg